Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myleoma”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Testing effectiveness (Phase 2)Looking for participantsNCT06952075
What this trial is testing

GR1803 Injection in Patients With RRMM

Who this might be right for
Multiple Myleoma
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 30
Large-scale testing (Phase 3)Looking for participantsNCT05645107
What this trial is testing

Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

Who this might be right for
HypogammaglobulinemiaBacterial InfectionsB-cell Chronic Lymphocytic Leukemia+2 more
Grifols Therapeutics LLC 386
Not applicableStudy completedNCT01584141
What this trial is testing

Study of Lymphoma in Asia

Who this might be right for
Lymphoma, FollicularLymphoma, Non-HodgkinMultiple Myleoma+3 more
National Cancer Institute (NCI) 13,433
Very early researchTemporarily pausedNCT06663046
What this trial is testing

Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma

Who this might be right for
Multiple MyleomaRefractory and Relapsed Multiple Myeloma
Wondercel Biotech (ShenZhen) 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06880601
What this trial is testing

Teclistamab Plus Autologous Lymphocyte Infusion (ALI) for the Treatment of R/R Multiple Myeloma

Who this might be right for
Multiple MyleomaMultiple Myeloma in RelapseMultiple Myeloma Refractory
Gruppo Italiano Malattie EMatologiche dell'Adulto 52
Testing effectiveness (Phase 2)Ended earlyNCT00074490
What this trial is testing

Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers

Who this might be right for
LymphomaLeukemiaMyeloproliferative Disorders+2 more
National Cancer Institute (NCI) 442